Algentech is a biotech company specializing in sustainable plant-based bioproduction. Its proprietary chloroplast technology enables efficient, scalable manufacturing of high-value biomolecules for the cosmetic, pharmaceutical, and food industries.
Algentech is a biotechnology company that specializes in sustainable bioproduction using plants as green factories. Its proprietary technology utilizes mini-chromosome amplification to enable high-yield expression of complex biomolecules, including proteins and nucleic acids, within chloroplasts. By leveraging plant systems, the company provides a scalable, cost-effective, and low-waste alternative to traditional manufacturing processes, tailored for the cosmetics, pharmaceutical, and food industries. The platform supports the production of high-value compounds such as melanin and antimicrobial enzymes like endolysins, which offer alternatives to conventional chemical synthesis and antibiotics.
This technology is significant for industrial partners seeking to adopt eco-friendly production methods. By harnessing CO2-consuming plant hosts, Algentech assists companies in reducing their environmental footprint while maintaining high-quality outputs. The firm has demonstrated its innovation through peer-reviewed research, such as publications in Nature Plants, and through collaborative engagements with major corporate partners, including its integration into the L'Oréal Green Science Incubator. Its service model includes both laboratory-scale proof-of-concept development and platform access for large-scale bioproduction.